Henry Wagner

13.0k citations

100 papers · 9.1k indexed · 5 hit papers · h-index 34

Impact in

Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
Oncology top 0.2%
- Lung Cancer Research Studies

Papers in

Pulmonary and Respiratory Medicine 60
- Lung Cancer Treatments and Mutations 33
- Lung Cancer Diagnosis and Treatment 29
Otorhinolaryngology 7

Co-authors: Arlene A. Forastiere John F. Ensley David H. Johnson Robert B. Livingston Jean‐Pierre Pignon R. Arriagada George L. Adams David J. Adelstein
Journals: Journal of Clinical Oncology (14 papers)International Journal of Radiation Oncology*Biology*Physics (9 papers)Lung Cancer (7 papers)New England Journal of Medicine (5 papers)Blood (5 papers)
Partner nations: United States Canada India

In The Last Decade

Henry Wagner

98 papers receiving 8.8k citations

Hit Papers

5 papers align trajectories log scale

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer 2012 · 835 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Journal of Clinical Oncology
2002 Journal of Clinical Oncology
1999 New England Journal of Medicine
1999 New England Journal of Medicine
1992 New England Journal of Medicine

Peers

Countries citing papers authored by Henry Wagner

Since Specialization

Citations

This map shows the geographic impact of Henry Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Wagner more than expected).

Fields of papers citing papers by Henry Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Wagner. The network helps show where Henry Wagner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henry Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Wagner Line = papers co-authored together Henry Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MA05.01 E6508: Phase II Study of Immunotherapy with Tecemotide and Bevacizumab after Chemoradiation in Unresectable Stage III NS-NSCLC Journal of Thoracic Oncology ·Jyoti D. Patel, Oygarden, Henry Wagner, D. Carbone, Anil Shanker, Leora Horn, Melissa L. Johnson, David E. Gerber, عامر هوام, Millie Das, Claudia Girnuweit, Christopher Dakhil, Suresh S. Ramalingam, Joan H. Schiller	2018	1
2	Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML International Journal of Hematology ·Kevin Rakszawski, Yong-ho Ahn, David F. Claxton, Henry Wagner, Hiroko Shike, Shin Mineishi, Seema Naik	2018	7
3	Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review Clinical Genitourinary Cancer ·Vijayavardhan Baireddy, Heath B. Mackley, Suhail M. Ali, Henry Wagner, Monika Joshi, Sheldon L. Holder, M. Kaag, Sylwia Kwarcińska, Giampaolo Talamo, Joseph J. Drabick	2016	2
4	Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627) Neuro-Oncology ·Andrew B. Lassman, Stephanie L. Pugh, Mark R. Gilbert, Kenneth Aldape, Sandrine Geinoz, Jan H. Beumer, Susan M. Christner, Ritsuko Komaki, Lisa M. DeAngelis, Rakesh Gaur, Emad Youssef, Henry Wagner, Minhee Won, Minesh P. Mehta	2015	106
5	The Impact of Protocol Assignment for Older Adolescents with Hodgkin Lymphoma Frontiers in Oncology ·Richard S. Pieters, Henry Wagner, Stephen P. Baker, A. D. Todd, Kenneth Ulin, M. Giulia Cicchetti, С.Б. Потемкин, Thomas J. FitzGerald	2014	8
6	Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496) Journal of Clinical Oncology ·Leo I. Gordon, Fangxin Hong, Richard I. Fisher, Nancy L. Bartlett, Joseph M. Connors, Randy D. Gascoyne, Henry Wagner, Patrick J. Stiff, Bruce D. Cheson, Mary Gospodarowicz, Ranjana H. Advani, Brad S. Kahl, Jonathan W. Friedberg, Kristie A. Blum, Thomas M. Habermann, Joseph M. Tuscano, Richard T. Hoppe, Sandra J. Horning	2012	194
7	Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer Journal of Thoracic Oncology ·Gerold Bepler, Thomas J. Dilling, Henry Wagner, Todd R. Hazelton, Charles C. Williams, Dung‐Tsa Chen, Harvey Greenberg, Frank Walsh, George R. Simon, Tawee Tanvetyanon, Alberto Chiappori, Eric B. Haura, Craig Stevens	2011	7
8	Multimodality Image Fusion and Planning and Dose Delivery for Radiation Therapy Medical dosimetry ·Cheng B. Saw, Vishwas S Phadke, J Háček, Henry Wagner	2008	9
9	Teflon granuloma results in a false-positive “second primary” on 18F-2-deoxyglucose positron emission tomography in a patient with a history of nasopharyngeal cancer American Journal of Otolaryngology ·Eleonora Flores-Ramírez, Ayesha N. Khalid, Henry Wagner, Brendan C. Stack	2007	5
10	Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590 Lung Cancer ·Heather A. Wakelee, Patricia Stephenson, Steven M. Keller, Henry Wagner, Arnold Herskovic, Ritsuko Komaki, Randolph S. Marks, Michael C. Perry, Robert B. Livingston, David H. Johnson	2005	42
11	Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease Journal of Thoracic and Cardiovascular Surgery ·Steven M. Keller, Márk Vangel, Henry Wagner, Joan H. Schiller, Arnold Herskovic, Ritsuko Komaki, Randolph S. Marks, Michael C. Perry, Robert B. Livingston, David H. Johnson	2004	72
12	Treatment of Stage IIIA Non-small Cell Lung Cancer* CHEST Journal ·Lary A. Robinson, Henry Wagner, John C. Ruckdeschel	2003	67
13	The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer Lung Cancer ·S.M. Keller, Márk Vangel, S. Adak, Henry Wagner, Joan H. Schiller, Arnold Herskovic, Ritsuko Komaki, Michael C. Perry, Randolph S. Marks, Robert B. Livingston, David H. Johnson	2002	37
14	Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593 International Journal of Radiation OncologyBiologyPhysics ·R M Auchter, Denise Scholtens, Sudeshna Adak, Henry Wagner, David Cella, Minesh P. Mehta	2001	39
15	Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer The Annals of Thoracic Surgery ·Steven M. Keller, Sudeshna Adak, Henry Wagner, David H. Johnson	2000	264
16	Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide New England Journal of Medicine ·Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum, William T. Sause, Robert B. Livingston, Ritsuko Komaki, Henry Wagner, Seena C. Aisner, David H. Johnson Hit paper breakdown →	1999	1015
17	A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas Journal of Neuro-Oncology ·Richard Hellman, Donna Neuberg, Henry Wagner, Margaret L. Grunnet, H. Ian Robins, Daniel D. Karp, Patrick Flynn, George L. Adams	1998	10
18	Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. Journal of Clinical Oncology ·Scot C. Remick, James J. McSharry, BC Wolf, Christina G. Blanchard, Ismail A. El-Fihail, Henry Wagner, Steven Tokarczyk, Crandall Jeff, D.F. Powell, Karjo Matajat	1993	43
19	Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. Journal of Clinical Oncology ·Robert C. Trueworthy, Jonathan J. Shuster, Thomas Look, WM Crist, M Borowitz, A J Carroll, Lawrence S. Frankel, M. Brennan Harris, Henry Wagner, M. E. Haggard	1992	168
20	Primary Central Nervous System Lymphoma in Patients with and without the Acquired Immune Deficiency Syndrome Medicine ·Scot C. Remick, Catherine Diamond, Grupo de Interés en Salud Indígena, Otelo G. Solis, Henry Wagner, Richard F. Haase, John C. Ruckdeschel	1990	89

About Henry Wagner

Henry Wagner is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology, Radiation and Pathology and Forensic Medicine, having authored 100 papers that have together received 9.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Research Studies (18 papers), Lymphoma Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (11 papers), Neuroendocrine Tumor Research Advances (8 papers), Medical Imaging Techniques and Applications (7 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Otorhinolaryngology (2.1k citations), Oncology (4.9k citations), Pulmonary and Respiratory Medicine (4.8k citations), Epidemiology (2.4k citations) and Genetics (656 citations). Henry Wagner has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Arlene A. Forastiere, John F. Ensley, David H. Johnson, Robert B. Livingston, Jean‐Pierre Pignon, R. Arriagada, George L. Adams, David J. Adelstein, Julie A. Kish and Yi Li. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Lung Cancer, New England Journal of Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact